Novo Nordisk A/S (ADR) (NYSE:NVO)

CAPS Rating: 4 out of 5

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 8:21:47 PM : Outperform Start Price: $108.63 NVO Score: +21.65

12/13

Featured Broker Partners


Advertisement